These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 12073773

  • 1. Proliferative activity (Ki-67), WT p53, Bcl-2 expression and their relationship to the tumor grade, in invasive ductal breast carcinomas.
    Kalogeraki A, Garbagnati F, Santinami M, Zoras O.
    In Vivo; 2002; 16(2):141-4. PubMed ID: 12073773
    [Abstract] [Full Text] [Related]

  • 2. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
    Wärnberg F, Nordgren H, Bergkvist L, Holmberg L.
    Br J Cancer; 2001 Sep 14; 85(6):869-74. PubMed ID: 11556839
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE, Malamou-Mitsi V, Kamina SA, Goussia AC, Agnantis NJ.
    Anticancer Res; 2000 Sep 14; 20(6B):4221-5. PubMed ID: 11205251
    [Abstract] [Full Text] [Related]

  • 9. Telomerase activity as a marker of invasive ductal breast carcinomas on FNABs and relationship to other prognostic variables.
    Kalogeraki A, Kafousi M, Ieromonachou P, Giannikaki E, Vrekoussis T, Zoras O, Tsiftsis D, Stathopoulos E.
    Anticancer Res; 2005 Sep 14; 25(3B):1927-30. PubMed ID: 16158927
    [Abstract] [Full Text] [Related]

  • 10. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer.
    Tsutsui S, Yasuda K, Suzuki K, Takeuchi H, Nishizaki T, Higashi H, Era S.
    BMC Cancer; 2006 Jul 13; 6():187. PubMed ID: 16839413
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 13. Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade.
    Mommers EC, Leonhart AM, Falix F, Michalides R, Meijer CJ, Baak JP, Diest PJ.
    J Pathol; 2001 Jul 12; 194(3):327-33. PubMed ID: 11439365
    [Abstract] [Full Text] [Related]

  • 14. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L, Chhieng DC, Bell WC, Grizzle WE, Frost AR.
    Biotech Histochem; 2008 Feb 12; 83(1):5-14. PubMed ID: 18568671
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.
    Am J Surg Pathol; 2008 Apr 12; 32(4):544-52. PubMed ID: 18300793
    [Abstract] [Full Text] [Related]

  • 17. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
    Cornfield DB, Palazzo JP, Schwartz GF, Goonewardene SA, Kovatich AJ, Chervoneva I, Hyslop T, Schwarting R.
    Cancer; 2004 Jun 01; 100(11):2317-27. PubMed ID: 15160334
    [Abstract] [Full Text] [Related]

  • 18. An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.
    O'Neill CJ, Deavers MT, Malpica A, Foster H, McCluggage WG.
    Am J Surg Pathol; 2005 Aug 01; 29(8):1034-41. PubMed ID: 16006797
    [Abstract] [Full Text] [Related]

  • 19. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS, Apple SK.
    Breast J; 2009 Aug 01; 15(2):146-54. PubMed ID: 19292800
    [Abstract] [Full Text] [Related]

  • 20. Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases.
    Kristek J, Dmitrović B, Kurbel S, Sakić K, Krajinović Z, Blazicević V, Has B, Marjanović K.
    Coll Antropol; 2007 Dec 01; 31(4):1043-7. PubMed ID: 18217456
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.